Business
PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board
PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board Canada...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n\n\n\nPharmaCielo Appoints New and Extended Medical and Scientific Advisory Board\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO and RIONEGRO, Colombia, April 9, 2019\n\n\n\nInternational panel of renowned physicians, researchers, veterinarians, engineers and academics Advisory Board to guide PharmaCielo's research and development of special cannabinoids-based formulations and derived products with therapeutic properties TORONTO and RIONEGRO, Colombia, April 9, 2019 /CNW/ - David Attard, Chief Executive Officer of PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce the appointment of the Company's extended Medical and Scientific Advisory Board (MSAB). \n\"Global adoption of medical cannabis therapy is nearing a tipping point as acceptance by governments, healthcare practitioners and the public reaches a critical mass,\" said David Attard, Chief Executive Officer with PharmaCielo. \"With the guidance of our new international Medical and Scientific Advisory Board, led by Dr. Delon Human, PharmaCielo is well positioned to become a global leader with medicinal cannabis offerings backed by enhanced medical and scientific research capabilities, advanced cultivation and extraction practices and the development of innovative products.\"\nThe mandate of the MSAB is to enhance PharmaCielo's research and product development plan, focused on the therapeutic properties of cannabinoid-based formulations. The MSAB will also provide guidance to PharmaCielo in safe and effective processes to use in the development of medicinal, consumer and pet health products – while adhering to stringent ethical research principles. \nDr. Delon Human, Global Head, Health and Innovation with PharmaCielo and Chair of the MSAB, noted, \"The therapeutic potential of cannabinoids in helping to reduce human suffering and illness and to enhance well-being is enormous, and we have only scratched t...